Smoking

Global Anti-Asthmatics & COPD Drugs Market Report 2015-2019 & 2020-2030 - Industry Anticipated to Cross $42 Billion by 2022 - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 7, 2019
Pharmaceutical, Health, Medical devices, Chronic lower respiratory diseases, Health, Medicine, Respiratory therapy, Articles, Habits, Chronic obstructive pulmonary disease, Asthma, Smoking

The global anti-asthmatics and COPD drugs market was valued at about $33.4 billion in 2018 and is expected to grow to $42.01 billion at a CAGR of 5.9% through 2022.

Key Points: 
  • The global anti-asthmatics and COPD drugs market was valued at about $33.4 billion in 2018 and is expected to grow to $42.01 billion at a CAGR of 5.9% through 2022.
  • Modifiable risk factors including smoking, lack of physical exercise, and unhealthy eating habits drive the Asthma and COPD drugs market.
  • Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
    4.3.
  • Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

Achieve Reports Financial Results for Third Quarter 2019 and Provides Update on Cytisinicline Development Program

Retrieved on: 
Wednesday, November 6, 2019
Smoking cessation, Human behavior, Health, Addiction, Health effects of tobacco, Smoking, Drug rehabilitation, General practice, Nicotine Anonymous, Nicotine replacement therapy

SEATTLE and VANCOUVER, British Columbia, Nov. 6, 2019 /PRNewswire/ --Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today provided an update on the cytisinicline clinical development program and announced third quarter 2019 financial results.

Key Points: 
  • SEATTLE and VANCOUVER, British Columbia, Nov. 6, 2019 /PRNewswire/ --Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today provided an update on the cytisinicline clinical development program and announced third quarter 2019 financial results.
  • Hosted Company's first Investor Day, including roundtable discussion with smoking cessation medical experts and presentation of final ORCA-1 data, including plans for Phase 3 development program.
  • Presented at the H.C. Wainwright 21st Annual Global Investment Conference and the Ladenburg Thalmann 2019 Healthcare Conference.
  • Achieve's focus is to address the global smoking health epidemic through the development and commercialization of cytisinicline.

Smokers Offered Fresh Hope With the UK Launch of VOKE

Retrieved on: 
Tuesday, November 5, 2019
Smoking cessation, Psychoactive drugs, Electronic cigarettes, Health, Addiction, Health effects of tobacco, Smoking, Electronic cigarette, Nicotine replacement therapy, Voke, Nicotine, Kind Consumer

LONDON, Nov. 5, 2019 /PRNewswire/ -- Today sees the UK launch of Voke , a new innovative nicotine delivery system designed to help smokers and vapers, quit or cut down.

Key Points: 
  • LONDON, Nov. 5, 2019 /PRNewswire/ -- Today sees the UK launch of Voke , a new innovative nicotine delivery system designed to help smokers and vapers, quit or cut down.
  • The nicotine inhaler is breath activated and uses advanced Vapourless Valve Technology (VVT) and is available to purchase directly online.
  • The pioneering technology used in Voke enables smokers to discreetly use this next generation Nicotine Replacement Therapy (NRT) to help relieve nicotine cravings rapidly.
  • By mimicking the many physical cues and the 'ritual' of smoking, Voke is set to be a game-changer for people who are seeking to quit smoking or cut down.

Smokers Offered Fresh Hope With the UK Launch of VOKE

Retrieved on: 
Tuesday, November 5, 2019
Smoking cessation, Psychoactive drugs, Human behavior, Health, Health effects of tobacco, Smoking, Nicotinic agonists, Electronic cigarettes, Electronic cigarette, Nicotine replacement therapy, Nicotine dependence, Nicotine

LONDON, Nov. 5, 2019 /PRNewswire/ -- Today sees the UK launch of Voke , a new innovative nicotine delivery system designed to help smokers and vapers, quit or cut down.

Key Points: 
  • LONDON, Nov. 5, 2019 /PRNewswire/ -- Today sees the UK launch of Voke , a new innovative nicotine delivery system designed to help smokers and vapers, quit or cut down.
  • The pioneering technology used in Voke enables smokers to discreetly use this next generation Nicotine Replacement Therapy (NRT) to help relieve nicotine cravings rapidly.
  • By mimicking the many physical cues and the 'ritual' of smoking, Voke is set to be a game-changer for people who are seeking to quit smoking or cut down.
  • Voke is the company's first product, which has been designed to combat the significant health problems of tobacco harm and tobacco dependence.

Westleaf Receives First White Label Order For Vape Pens

Retrieved on: 
Monday, November 4, 2019
Smoking, Electronic cigarettes, Crops, Smoking cessation, Carcinogens, Electronic cigarette, Cannabis, Hemp, Vape shop

"This is another important milestone in the development of Westleaf, as we add the critical processing and manufacturing component to our vertically integrated strategy," said Scott Hurd, President and CEO of Westleaf.

Key Points: 
  • "This is another important milestone in the development of Westleaf, as we add the critical processing and manufacturing component to our vertically integrated strategy," said Scott Hurd, President and CEO of Westleaf.
  • The White-Label Agreement provides for Westleaf Labs to produce a minimum of ~$4 million of white labelled cannabis derivative products, with the option to increase to $16 million per annum.
  • Delta 9 Order The initial order represents anticipated revenue of ~$740,000 over three months.
  • Safe and Regulated Products The production of vape pens and cartridges at The Plant by Westleaf Labs, as well as the entire Westleaf supply chain, will be highly regulated and adhere to the strictest safety standards of Health Canada.

Kanvas Revolutionizes Cannabis Industry with Launch of First and Only Certified Child-Resistant All-in-One Disposable Vaporizer

Retrieved on: 
Thursday, October 31, 2019
Smoking, Electronic cigarettes, Articles, Carcinogens, Dosage forms, Smoking cessation, Electronic cigarette, Vaporizer, Disposable product, Electric battery, Kanva

Additional benefits of Kanvas fail-safe design include prolonged battery life, auto-firing restriction and protection from the very first hit.

Key Points: 
  • Additional benefits of Kanvas fail-safe design include prolonged battery life, auto-firing restriction and protection from the very first hit.
  • We are proud to be the first in our industry to introduce an end-to-end vape solution with certified child-resistant functionality, said Andy Fathollahi, Kanvas CEO.
  • Unlike devices from other hardware manufacturers, the Kanvas Child-Resistant Disposable Vaporizer is the first and only complete device that offers peace of mind out of the box.
  • For more information about the Kanvas Child-Resistant Disposable Vaporizer, visit www.thekanvasco.com .

Achieve Life Sciences to Announce Third Quarter 2019 Financial Results and Host Conference Call and Webcast on November 6, 2019

Retrieved on: 
Thursday, October 31, 2019
Smoking, Psychoactive drugs, Addiction, Human behavior, Nicotine Anonymous, Nicotine, Smoking cessation, Conference call

SEATTLEand VANCOUVER, British Columbia, Oct. 31, 2019 /PRNewswire/ --Achieve Life Sciences, Inc. (Nasdaq: ACHV),a clinical-stage pharmaceutical company committed to the global development and commercialization ofcytisiniclinefor smoking cessation and nicotine addiction, today announced that it will report itsthirdquarter2019financial results onWednesday, November 6,2019.Company management will host a conference call and live webcast at 8:00am Eastern Time to report financial results and provide an update on thecytisinicline clinical development program.

Key Points: 
  • SEATTLEand VANCOUVER, British Columbia, Oct. 31, 2019 /PRNewswire/ --Achieve Life Sciences, Inc. (Nasdaq: ACHV),a clinical-stage pharmaceutical company committed to the global development and commercialization ofcytisiniclinefor smoking cessation and nicotine addiction, today announced that it will report itsthirdquarter2019financial results onWednesday, November 6,2019.Company management will host a conference call and live webcast at 8:00am Eastern Time to report financial results and provide an update on thecytisinicline clinical development program.
  • To access the webcast, log on to the Investor Relations page of the Achieve website at http://ir.achievelifesciences.com/events-and-webcasts .
  • Alternatively, you may access the live conference call by dialing (877) 472-9809 (U.S. & Canada) or (629) 228-0791 (International) and referencingconferenceID7196429.
  • Awebcast replay will be available approximately two hours after the call and will be archived on the website for 90 days.

RELX Technology Presents Its Smart E-cigarette RELX i at Shanghai International e-Cigarette Industry Expo (IECIE)

Retrieved on: 
Wednesday, October 30, 2019
Technology, Tobacco, Retail, Consumer electronics, Electronic cigarettes, Tobacco, Smoking, Carcinogens, RELX, Cigarette, Electronic cigarette, blu eCigs

Asias leading independent e-cigarette brand RELX presented its latest product, a Bluetooth-enabled intelligent e-cigarette called the RELX i, at the International e-Cigarette Industry Expo (IECIE) in Shanghai.

Key Points: 
  • Asias leading independent e-cigarette brand RELX presented its latest product, a Bluetooth-enabled intelligent e-cigarette called the RELX i, at the International e-Cigarette Industry Expo (IECIE) in Shanghai.
  • The RELX i, RELX Technologys latest product line launched in August 2019, is the first-ever intelligent e-cigarette in the Chinese market.
  • RELX Technology has always placed social responsibility, user experience, and product quality above everything else, said Jiang Long, co-founder of RELX Technology.
  • According to market consultancy Euromonitor, RELX Technology holds over 44% of the China market by the first half of 2019.

Global Tobacco Market 2019-2023 | Increasing Use of Automated Techniques in Manufacturing to Boost Growth | Technavio

Retrieved on: 
Tuesday, October 29, 2019
Tobacco, Retail, Carcinogens, Habits, Entheogens, Leaves, Tobacco, Smoking, Smokeless tobacco, Cigar, Electronic cigarette, Snus

View the full release here: https://www.businesswire.com/news/home/20191029005920/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20191029005920/en/
    Technavio has announced its latest market research report titled global tobacco market 2019-2023.
  • Thus, the rising demand for cigars and smoking tobacco products will boost the growth of the global tobacco market during the forecast period.
  • Thus, with the increasing use of automated techniques in the manufacture of tobacco products, will boost market growth during the forecast period.
  • This market research report segments the global tobacco market by product (combustible tobacco products and smokeless tobacco products) and geographical regions (APAC, Europe, North America, MEA, and South America).

Dickey’s New VP of IT Teams Up With Franchisees to Revamp Tech Strategy

Retrieved on: 
Tuesday, October 29, 2019
Food and drink, Personal life, Cooking, American cuisine, Dickey's Barbecue Pit, Smoked meat, Earth oven, Dicky, Dickey, Barbecue, Smoking

Under De Santis direction, this month the Dickeys website will be overhauled.

Key Points: 
  • Under De Santis direction, this month the Dickeys website will be overhauled.
  • In addition, Dickeys franchisees will see improvements to their online ordering portal with functionality enhancements expected to roll out before the busy holiday catering season.
  • At Dickeys, all our barbecued meats are smoked on-site in a hickory wood burning pit for up to 14 hours.
  • Dickey's Barbecue Pit has also been recognized by Franchise Times, The Wall Street Journal, QSR Magazine, Forbes Magazine and Nation's Restaurant News.